Allspring Global Investments Holdings LLC lowered its position in shares of Encompass Health Co. (NYSE:EHC – Get Rating) by 55.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,626 shares of the company’s stock after selling 9,543 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Encompass Health were worth $344,000 at the end of the most recent reporting period.
A number of other institutional investors have also made changes to their positions in the stock. Baupost Group LLC MA grew its stake in shares of Encompass Health by 318.9% during the first quarter. Baupost Group LLC MA now owns 3,000,000 shares of the company’s stock worth $213,330,000 after purchasing an additional 2,283,900 shares during the period. State Street Corp grew its stake in shares of Encompass Health by 5.0% during the first quarter. State Street Corp now owns 2,733,254 shares of the company’s stock worth $195,118,000 after purchasing an additional 130,504 shares during the period. Victory Capital Management Inc. grew its stake in shares of Encompass Health by 40.0% during the second quarter. Victory Capital Management Inc. now owns 2,146,910 shares of the company’s stock worth $120,335,000 after purchasing an additional 613,547 shares during the period. Massachusetts Financial Services Co. MA grew its stake in shares of Encompass Health by 88.8% during the second quarter. Massachusetts Financial Services Co. MA now owns 1,685,880 shares of the company’s stock worth $94,494,000 after purchasing an additional 792,813 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in shares of Encompass Health by 21.0% during the first quarter. Dimensional Fund Advisors LP now owns 1,464,313 shares of the company’s stock worth $104,127,000 after purchasing an additional 254,385 shares during the period. 96.14% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at Encompass Health
In related news, Director Greg D. Carmichael bought 1,830 shares of the company’s stock in a transaction that occurred on Monday, October 31st. The shares were acquired at an average price of $54.67 per share, for a total transaction of $100,046.10. Following the completion of the acquisition, the director now owns 10,546 shares of the company’s stock, valued at approximately $576,549.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 2.70% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Encompass Health Stock Down 0.9 %
EHC stock opened at $61.70 on Wednesday. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.21 and a quick ratio of 1.21. The stock has a market capitalization of $6.16 billion, a P/E ratio of 22.68, a P/E/G ratio of 2.64 and a beta of 1.02. The business has a 50-day moving average of $58.64 and a 200-day moving average of $53.44. Encompass Health Co. has a fifty-two week low of $44.33 and a fifty-two week high of $74.61.
Encompass Health (NYSE:EHC – Get Rating) last posted its quarterly earnings data on Wednesday, October 26th. The company reported $0.67 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.01). The firm had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.06 billion. Encompass Health had a return on equity of 15.59% and a net margin of 5.39%. On average, sell-side analysts anticipate that Encompass Health Co. will post 2.79 earnings per share for the current fiscal year.
Encompass Health Company Profile
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.
- Get a free copy of the StockNews.com research report on Encompass Health (EHC)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- When Will Crane Holdings Take Flight?
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.